225 related articles for article (PubMed ID: 35426962)
1. "Just give them a choice": Patients' perspectives on starting medications for opioid use disorder in the ED.
Schoenfeld EM; Westafer LM; Beck SA; Potee BG; Vysetty S; Simon C; Tozloski JM; Girardin AL; Soares WE
Acad Emerg Med; 2022 Aug; 29(8):928-943. PubMed ID: 35426962
[TBL] [Abstract][Full Text] [Related]
2. Comparing Reasons for Starting and Stopping Methadone, Buprenorphine, and Naltrexone Treatment Among a Sample of White Individuals With Opioid Use Disorder.
Randall-Kosich O; Andraka-Christou B; Totaram R; Alamo J; Nadig M
J Addict Med; 2020; 14(4):e44-e52. PubMed ID: 31651562
[TBL] [Abstract][Full Text] [Related]
3. Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.
Yarborough BJ; Stumbo SP; McCarty D; Mertens J; Weisner C; Green CA
Drug Alcohol Depend; 2016 Mar; 160():112-8. PubMed ID: 26796596
[TBL] [Abstract][Full Text] [Related]
4. Emergency department utilization by individuals with opioid use disorder who were recently incarcerated.
Will J; Abare M; Olson M; Chyorny A; Wilhelm-Leen E
J Subst Abuse Treat; 2022 Oct; 141():108838. PubMed ID: 35868162
[TBL] [Abstract][Full Text] [Related]
5. "You have to take this medication, but then you get punished for taking it:" lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period.
Schiff DM; Work EC; Muftu S; Partridge S; MacMillan KDL; Gray JR; Hoeppner BB; Kelly JF; Greenfield SF; Jones HE; Wilens TE; Terplan M; Bernstein J
J Subst Abuse Treat; 2022 Aug; 139():108765. PubMed ID: 35341614
[TBL] [Abstract][Full Text] [Related]
6. Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting.
Carswell N; Angermaier G; Castaneda C; Delgado F
Hosp Pract (1995); 2022 Oct; 50(4):251-258. PubMed ID: 35837678
[TBL] [Abstract][Full Text] [Related]
7. METHADONE INITIATION IN THE EMERGENCY DEPARTMENT FOR OPIOID USE DISORDER: A CASE SERIES.
Huo S; Heil J; Salzman MS; Carroll G; Haroz R
J Emerg Med; 2023 Mar; 64(3):391-396. PubMed ID: 37019500
[TBL] [Abstract][Full Text] [Related]
8. Buprenorphine use and disparities in access among emergency department patients with opioid use disorder: A cross-sectional study.
Robbins M; Haroz R; Mazzarelli A; Clements D; Jones CW; Salzman M
J Subst Abuse Treat; 2021 Nov; 130():108405. PubMed ID: 34118697
[TBL] [Abstract][Full Text] [Related]
9. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
[TBL] [Abstract][Full Text] [Related]
10. Attitudes on Methadone Utilization in the Emergency Department: A Physician Cross-sectional Study.
Heil J; Ganetsky VS; Salzman MS; Hunter K; Baston KE; Carroll G; Ketcham E; Haroz R
West J Emerg Med; 2022 Apr; 23(3):386-395. PubMed ID: 35679506
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community.
Biondi BE; Vander Wyk B; Schlossberg EF; Shaw A; Springer SA
Addict Sci Clin Pract; 2022 Mar; 17(1):15. PubMed ID: 35255967
[TBL] [Abstract][Full Text] [Related]
12. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings.
Frost MC; Soyer EM; Achtmeyer CE; Hawkins EJ; Glass JE; Hallgren KA; Williams EC
Addict Sci Clin Pract; 2023 May; 18(1):26. PubMed ID: 37143162
[TBL] [Abstract][Full Text] [Related]
13. Prior use of medications for opioid use disorder in ED patients with opioid overdose: prevalence, misuse and overdose severity.
Shastry S; Nobel I; Allen LR; Richardson LD; Vidal K; Manini AF
Am J Emerg Med; 2022 Jan; 51():114-118. PubMed ID: 34735968
[TBL] [Abstract][Full Text] [Related]
14. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
Sufrin C; Sutherland L; Beal L; Terplan M; Latkin C; Clarke JG
Addiction; 2020 Nov; 115(11):2057-2065. PubMed ID: 32141128
[TBL] [Abstract][Full Text] [Related]
15. Stigmatization of medications for opioid use disorder in 12-step support groups and participant responses.
Andraka-Christou B; Totaram R; Randall-Kosich O
Subst Abus; 2022; 43(1):415-424. PubMed ID: 34214400
[No Abstract] [Full Text] [Related]
16. Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs.
Hughto JMW; Tapper A; Rapisarda SS; Stopka TJ; Palacios WR; Case P; Silcox J; Moyo P; Green TC
Subst Abuse Treat Prev Policy; 2023 May; 18(1):30. PubMed ID: 37217975
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder.
Cioe K; Biondi BE; Easly R; Simard A; Zheng X; Springer SA
J Subst Abuse Treat; 2020 Dec; 119():108146. PubMed ID: 33138929
[TBL] [Abstract][Full Text] [Related]
18. Managing emergency department patients with opioid use disorder.
Hazekamp CS; Sacco D
Emerg Med Pract; 2024 Jun; 26(6):1-24. PubMed ID: 38768011
[TBL] [Abstract][Full Text] [Related]
19. Variability in opioid use disorder clinical presentations and treatment in the emergency department: A mixed-methods study.
Faude S; Delgado MK; Perrone J; McFadden R; Xiong RA; O'Donnell N; Wood C; Solomon G; Lowenstein M
Am J Emerg Med; 2023 Apr; 66():53-60. PubMed ID: 36706482
[TBL] [Abstract][Full Text] [Related]
20. A retrospective, observational study on medication for opioid use disorder during pregnancy and risk for neonatal abstinence syndrome.
Sujan A; Cleary E; Douglas E; Aujla R; Boyars L; Smith C; Guille C
Fam Pract; 2022 Mar; 39(2):311-315. PubMed ID: 34537839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
